Among the most important events in connective tissue physiology are the nucleation, growth and calcification of collagen fibrils. It has been speculated that all are associated with, or even controlled by collagen-proteoglycan interactions. We therefore developed methods for investigating these associations in tissues, particularly for understanding their significance for type I collagen, the commonest form of collagen in the body, especially predominant in bone. Using an electron-dense dye, Cupromeronic blue, in the 'critical electrolyte concentration' mode, and digestion by hyaluronidase, chondroitinase ABC or keratanase, supported by biochemical analyses, we found that dermatan sulphate proteoglycan of soft connective tissue (skin, tendon, cornea) was regularly and orthogonally arrayed at the fibril surface, at the d or e band. Keratan sulphate proteoglycan in the cornea associates orthogonally at the a and c bands. Bone, demineralized by a non-aqueous technique which retains proteoglycans in the tissue, does not contain orthogonal arrays; the interfibrillar proteoglycan filaments are oriented parallel to the fibril axis. The main proteoglycan in bone is chondroitin sulphate-rich. There are thus four separate specific binding sites on type I collagen fibrils, each one associating with one particular proteoglycan, and apparently no other. This implies that there are two corresponding binding sites in each proteoglycan. Available evidence shows that there are two species of small dermatan sulphate and keratan sulphate proteoglycans. It is suggested that each species is specific for its own band (a, c, d or e). Hyaluronate and chondroitin sulphate are probably mainly interfibrillar, acting in a space-filling capacity.